Compare Japan Lifeline Co., Ltd. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 14.22%
2
Company has very low debt and has enough cash to service the debt requirements
3
Poor long term growth as Operating profit has grown by an annual rate 1.71% of over the last 5 years
4
Negative results in Jun 25
5
With ROE of 15.74%, it has a very attractive valuation with a 1.85 Price to Book Value
6
Below par performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
JPY 114,864 Million (Small Cap)
12.00
NA
0.00%
-0.10
16.02%
1.88
Revenue and Profits:
Net Sales:
14,669 Million
(Quarterly Results - Sep 2025)
Net Profit:
2,472 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.92%
0%
-3.92%
6 Months
0.22%
0%
0.22%
1 Year
-13.65%
0%
-13.65%
2 Years
5.43%
0%
5.43%
3 Years
56.9%
0%
56.9%
4 Years
38.01%
0%
38.01%
5 Years
-1.06%
0%
-1.06%
Japan Lifeline Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.81%
EBIT Growth (5y)
1.71%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
0.88
Tax Ratio
22.51%
Dividend Payout Ratio
40.33%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.47%
ROE (avg)
14.22%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
1.85
EV to EBIT
9.11
EV to EBITDA
7.79
EV to Capital Employed
1.97
EV to Sales
1.83
PEG Ratio
0.59
Dividend Yield
NA
ROCE (Latest)
21.62%
ROE (Latest)
15.74%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
14,669.00
14,616.00
0.36%
Operating Profit (PBDIT) excl Other Income
3,755.00
3,677.00
2.12%
Interest
9.00
9.00
Exceptional Items
-16.00
-3.00
-433.33%
Consolidate Net Profit
2,472.00
2,302.00
7.38%
Operating Profit Margin (Excl OI)
228.00%
223.90%
0.41%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is 0.36% vs 5.92% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is 7.38% vs 2.49% in Jun 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
56,610.00
51,384.00
10.17%
Operating Profit (PBDIT) excl Other Income
14,617.00
12,827.00
13.95%
Interest
36.00
26.00
38.46%
Exceptional Items
-335.00
-660.00
49.24%
Consolidate Net Profit
9,317.00
7,515.00
23.98%
Operating Profit Margin (Excl OI)
221.20%
214.80%
0.64%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 10.17% vs -0.71% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 23.98% vs 9.06% in Mar 2024
About Japan Lifeline Co., Ltd. 
Japan Lifeline Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






